[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Viral N. Shah\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":43},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":28,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100615079","to-study-the-efficacy-and-safety-of-medtronic-780g-insulin-pump-in-people-with-gastroparesis-and-type-1-diabetes-100615079",false,"NCT07287943","To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.","Efficacy and Safety of Medtronic 780G Automated Insulin Delivery System in Adults With Type 1 Diabetes and Gastroparesis","Inclusion criteria\n\n* Age ≥18 years\n* Diagnosis of T1D for at least 12 months with stable insulin regimen for at least 2 months\n* HbA1c ≥8.0%\n* Diagnosis of gastroparesis per National Institute of Health (NIH) definition\n* Willing to use Medtronic 780G system either with Simplera CGM.\n* Ability to provide informed consent before any trial-related activities\n* If randomized to usual care group and on an insulin pump already, should be willing to use pump in manual mode only for the duration of the study\n\nExclusion criteria\n\n* Age \\\u003C18 years\n* Current use of inhaled insulin (Afrezza)\n* Patients with T1D using any glucose lowering medications other than insulin at the time of screening\n* Pregnancy, breast feeding, or wanting to become pregnant\n* Current use (≥ 2 weeks of continuous use) of any steroidal medication, or anticipated long-term steroidal treatment (\\>4 weeks continuously), during the study period\n* History of gastric outlet obstruction or other gastrointestinal structural abnormalities\n* Estimated glomerular filtration rate (eGFR) \\\u003C30 or on dialysis\n* History of SH in the previous 3 months\n* History of two or more episodes DKA requiring hospitalization in the past 12 months\n* Any medical (such as severe cardiovascular disease, malignancy, chronic liver disease) or psychosocial conditions that make a person unfit for the study at the discretion of investigators\n* Use of investigational drugs within 5 half-lives prior to screening\n* Current use of cannabis or history of cannabinoid hyperemesis syndrome","ALL","18 Years",{"count":19,"type":20},34,"ESTIMATED","INTERVENTIONAL",[23],"NA","The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.",[26,27],"Type 1 Diabetes","Gastroparesis Due to Diabetes Mellitus Type I",[29,30],"type 1 diabetes","gastroparesis","RECRUITING","2026-02-14",{"date":34,"type":35},"2026-02-18","ACTUAL",{"date":37,"type":35},"2026-02-09",{"date":39,"type":20},"2026-12-01",{"name":41,"class":42},"Viral N. Shah","OTHER",""]